Get started
PetMed Express, Inc.PetMed Express, Inc.PetMed Express, Inc.

PetMed Express, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

PETS chart


Full chart

PETS upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪90.27 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
408.41
Basic EPS (TTM)
0.02 USD
Net income (FY)
‪−7.46 M‬ USD
Revenue (FY)
‪281.06 M‬ USD
Shares float
‪17.02 M‬
Beta (1Y)
1.70

Employees


Employees (FY)
287
Change (1Y)
−15 −4.97%
Revenue / Employee (1Y)
‪979.32 K‬ USD
Net income / Employee (1Y)
‪−26.01 K‬ USD

About PetMed Express, Inc.


Sector
Retail Trade
Industry
Specialty Stores
CEO
Sandra Y. Campos
Website
1800petmeds.com
Headquarters
Delray Beach
Founded
1996
FIGI
BBG000BDYQR4
PetMed Express, Inc. provides markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, heart/blood pressure, and other specialty medications, and generic substitutes. The company was founded in January 1996 and is headquartered in Delray Beach, FL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

PETS news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of PETS is 4.39 USD — it has increased by 0.69% in the past 24 hours. Watch PetMed Express, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange PetMed Express, Inc. stocks are traded under the ticker PETS.
PETS stock has fallen by −2.44% compared to the previous week, the month change is a −11.29% fall, over the last year PetMed Express, Inc. has showed a −15.74% decrease.
We've gathered analysts' opinions on PetMed Express, Inc. future price: according to them, PETS price has a max estimate of 4.00 USD and a min estimate of 3.50 USD. Watch PETS chart and read a more detailed PetMed Express, Inc. stock forecast: see what analysts think of PetMed Express, Inc. and suggest that you do with its stocks.
PETS reached its all-time high on Jan 22, 2018 with the price of 57.80 USD, and its all-time low was 0.09 USD and was reached on Feb 2, 2001. View more price dynamics on PETS chart.
See other stocks reaching their highest and lowest prices.
PETS stock is 4.00% volatile and has beta coefficient of 1.70. Track PetMed Express, Inc. stock price on the chart and check out the list of the most volatile stocks — is PetMed Express, Inc. there?
Today PetMed Express, Inc. has the market capitalization of ‪90.27 M‬, it has increased by 3.76% over the last week.
Yes, you can track PetMed Express, Inc. financials in yearly and quarterly reports right on TradingView.
PetMed Express, Inc. is going to release the next earnings report on May 12, 2025. Keep track of upcoming events with our Earnings Calendar.
PETS earnings for the last quarter are −0.03 USD per share, whereas the estimation was 0.01 USD resulting in a −700.00% surprise. The estimated earnings for the next quarter are −0.04 USD per share. See more details about PetMed Express, Inc. earnings.
PetMed Express, Inc. revenue for the last quarter amounts to ‪52.98 M‬ USD, despite the estimated figure of ‪60.00 M‬ USD. In the next quarter, revenue is expected to reach ‪54.00 M‬ USD.
PETS net income for the last quarter is ‪−707.00 K‬ USD, while the quarter before that showed ‪2.33 M‬ USD of net income which accounts for −130.40% change. Track more PetMed Express, Inc. financial stats to get the full picture.
Yes, PETS dividends are paid quarterly. The last dividend per share was 0.30 USD. As of today, Dividend Yield (TTM)% is 0.00%. Tracking PetMed Express, Inc. dividends might help you take more informed decisions.
As of Feb 24, 2025, the company has 287.00 employees. See our rating of the largest employees — is PetMed Express, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PetMed Express, Inc. EBITDA is ‪7.44 M‬ USD, and current EBITDA margin is 0.03%. See more stats in PetMed Express, Inc. financial statements.
Like other stocks, PETS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PetMed Express, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PetMed Express, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PetMed Express, Inc. stock shows the sell signal. See more of PetMed Express, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.